Chemoinformaics analysis of 25-Hydroxy-33-methylpentatricontan-6-one
| Molecular Weight | 536.97 | nRot | 32 |
| Heavy Atom Molecular Weight | 464.394 | nRig | 28 |
| Exact Molecular Weight | 536.553 | nRing | 0 |
| Solubility: LogS | -2.739 | nHRing | 0 |
| Solubility: LogP | 0.981 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 110 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 109.733 |
| nHD | 1 | BPOL | 73.0989 |
| QED | 0.685 |
| Synth | 7.793 |
| Natural Product Likeliness | 3.616 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.156 |
| Pgp-sub | 0.284 |
| HIA | 0.025 |
| CACO-2 | -4.994 |
| MDCK | 0.0000588 |
| BBB | 0.517 |
| PPB | 0.242465 |
| VDSS | 1.594 |
| FU | 0.580718 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.721 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.028 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.437 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.525 |
| CL | 14.967 |
| T12 | 0.031 |
| hERG | 0.035 |
| Ames | 0.067 |
| ROA | 0.595 |
| SkinSen | 0.057 |
| Carcinogencity | 0.026 |
| EI | 0.004 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.64949 |